Christine L. Clarke
University of Sydney
150 Papers
1.7K Citations
Christine L. Clarke is an academic researcher from University of Sydney. The author has contributed to research in topics: Breast cancer & Progesterone receptor. The author has an hindex of 52, co-authored 144 publications. Previous affiliations of Christine L. Clarke include Millennium Institute & Westmead Hospital.
Chat about Author
Papers
Patent
Systems and methods for identifying cancers having activated progesterone receptors
Christine L. Clarke,J. Dinny Graham +1 more
- 12 Mar 2015
TL;DR: In this article, a system and methods for identifying tumors having activated progesterone receptors are provided. Patients suspected of having a tumor susceptible to growth inhibition by antiprogestins can be treated with an anti-progestin.
4
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Thomas U. Ahearn,Haoyu Zhang,Haoyu Zhang,Kyriaki Michailidou,Kyriaki Michailidou,Roger L. Milne,Roger L. Milne,Roger L. Milne,Manjeet K. Bolla,Joe Dennis,Alison M. Dunning,Michael Lush,Qin Wang,Irene L. Andrulis,Irene L. Andrulis,Hoda Anton-Culver,Volker Arndt,Kristan J. Aronson,Paul L. Auer,Paul L. Auer,Annelie Augustinsson,Adinda Baten,Heiko Becher,Sabine Behrens,Javier Benitez,Marina Bermisheva,Marina Bermisheva,Carl Blomqvist,Carl Blomqvist,Stig E. Bojesen,Stig E. Bojesen,Bernardo Bonanni,Anne Lise Børresen-Dale,Anne Lise Børresen-Dale,Hiltrud Brauch,Hiltrud Brauch,Hiltrud Brauch,Hermann Brenner,Angela Brooks-Wilson,Angela Brooks-Wilson,Thomas Brüning,Barbara Burwinkel,Barbara Burwinkel,Saundra S. Buys,Federico Canzian,Jose E. Castelao,Jenny Chang-Claude,Jenny Chang-Claude,Stephen J. Chanock,Georgia Chenevix-Trench,Christine L. Clarke,J. Margriet Collée,Angela Cox,Simon S. Cross,Kamila Czene,Mary B. Daly,Peter Devilee,Thilo Dörk,Miriam Dwek,Diana Eccles,D. Gareth Evans,Peter A. Fasching,Jonine D. Figueroa,Giuseppe Floris,Manuela Gago-Dominguez,Susan M. Gapstur,José A. García-Sáenz,Mia M. Gaudet,Graham G. Giles,Graham G. Giles,Graham G. Giles,Mark S. Goldberg,Anna González-Neira,Grethe I. GrenakerAlnæs,Mervi Grip,Pascal Guénel,Christopher A. Haiman,Per Hall,Ute Hamann,Elaine F. Harkness,Elaine F. Harkness,Bernadette A M Heemskerk-Gerritsen,Bernd Holleczek,Antoinette Hollestelle,Maartje J. Hooning,Robert N. Hoover,John L. Hopper,Anthony Howell,kConFab,Aocs Investigators,Milena Jakimovska,Milena Jakimovska,Anna Jakubowska,Esther M. John,Michael Jones,Audrey Y. Jung,Rudolf Kaaks,Saila Kauppila,Renske Keeman,Renske Keeman,Elza Khusnutdinova,Cari M. Kitahara,Yon-Dschun Ko,Stella Koutros,Stella Koutros,Vessela N. Kristensen,Ute Krüger,Kubelka-Sabit K,Allison W. Kurian,Kyriacos Kyriacou,Diether Lambrechts,Derrick G. Lee,Derrick G. Lee,Annika Lindblom,Martha S. Linet,Jolanta Lissowska,Ana Llaneza,Ana Llaneza,Wing-Yee Lo,Wing-Yee Lo,Robert J. MacInnis,Arto Mannermaa,Mehdi Manoochehri,Sara Margolin,Maria Elena Martinez,Catriona McLean,A. Meindl,Usha Menon,H Nevanlinna,William G. Newman,Jesse Nodora,Kenneth Offit,Håkan Olsson,Nick Orr,Tjoung-Won Park-Simon,Alpa V. Patel,Julian Peto,Guillermo Pita,Dijana Plaseska-Karanfilska,Ross Prentice,Kevin Punie,Katri Pylkäs,Paolo Radice,Gad Rennert,Atocha Romero,Thomas Rüdiger,Emmanouil Saloustros,Sarah Sampson,Dale P. Sandler,Elinor J. Sawyer,Rita K. Schmutzler,Minouk J. Schoemaker,Minouk J. Schoemaker,Ben Schöttker,Mark E. Sherman,Xiao-Ou Shu,Snezhana Smichkoska,Snezhana Smichkoska,Snezhana Smichkoska,Melissa C. Southey,John J. Spinelli,Anthony J Swerdlow,Rulla M. Tamimi,William J. Tapper,Jack A. Taylor,Lauren R. Teras,Mary Beth Terry,Mary Beth Terry,Diana Torres,Melissa A Troester,Celine M. Vachon,Carolien H.M. van Deurzen,Elke M. van Veen,Philippe Wagner,Clarice R. Weinberg,Camilla Wendt,Jelle Wesseling,Robert Winqvist,Robert Winqvist,Alicja Wolk,Xiaohong R. Yang,Wei Zheng,Fergus J. Couch,Jacques Simard,Peter Kraft,Douglas F. Easton,Paul D.P. Pharoah,Marjanka K. Schmidt,Montserrat Garcia-Closas,Nilanjan Chatterjee +189 more
TL;DR: In this article, the authors used two-stage polytomous logistic regression models to evaluate variants in relation to multiple tumor features (ER, progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and grade) adjusting for each other.
4
Estrogen and progesterone receptor variants in human breast cancer
TL;DR: Recently variant forms of estrogen receptor and progesterone receptor have been shown to exist in breast cancer tumors and in cell line.
4
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Jingjing Liu,Jingjing Liu,Wendy J. C. Prager van der Smissen,J. Margriet Collée,Manjeet K. Bolla,Qin Wang,Kyriaki Michailidou,Kyriaki Michailidou,Joe Dennis,Thomas U. Ahearn,Kristiina Aittomäki,Christine B. Ambrosone,Irene L. Andrulis,Irene L. Andrulis,Hoda Anton-Culver,Natalia Antonenkova,Volker Arndt,Norbert Arnold,Kristan J. Aronson,Annelie Augustinsson,Päivi Auvinen,Heiko Becher,Heiko Becher,Matthias W. Beckmann,Sabine Behrens,Marina Bermisheva,Leslie Bernstein,Natalia Bogdanova,Nadja Bogdanova-Markov,Stig E. Bojesen,Stig E. Bojesen,Hiltrud Brauch,Hiltrud Brauch,Hiltrud Brauch,Hermann Brenner,Ignacio Briceño,Ignacio Briceño,Sara Y. Brucker,Thomas Brüning,Barbara Burwinkel,Barbara Burwinkel,Qiuyin Cai,Hui Cai,Daniele Campa,Daniele Campa,Federico Canzian,Jose E. Castelao,Jenny Chang-Claude,Jenny Chang-Claude,Stephen J. Chanock,Ji Yeob Choi,Melissa Christiaens,Christine L. Clarke,Fergus J. Couch,Kamila Czene,Mary B. Daly,Peter Devilee,Isabel dos-Santos-Silva,Miriam Dwek,Diana Eccles,A. Heather Eliassen,A. Heather Eliassen,Peter A. Fasching,Peter A. Fasching,Jonine D. Figueroa,Jonine D. Figueroa,Henrik Flyger,Lin Fritschi,Manuela Gago-Dominguez,Susan M. Gapstur,Montserrat Garcia-Closas,José A. García-Sáenz,Mia M. Gaudet,Graham G. Giles,Graham G. Giles,Graham G. Giles,Mark S. Goldberg,David E. Goldgar,Pascal Guénel,Christopher A. Haiman,Niclas Håkansson,Per Hall,Patricia Harrington,Steven N. Hart,Mikael Hartman,Mikael Hartman,Peter Hillemanns,John L. Hopper,Ming-Feng Hou,David J. Hunter,David J. Hunter,Dezheng Huo,Hidemi Ito,Motoki Iwasaki,Milena Jakimovska,Anna Jakubowska,Anna Jakubowska,Esther M. John,Rudolf Kaaks,Daehee Kang,Daehee Kang,Renske Keeman,Elza Khusnutdinova,Elza Khusnutdinova,Sung-Won Kim,Peter Kraft,Vessela N. Kristensen,Allison W. Kurian,Loic Le Marchand,Jingmei Li,Annika Lindblom,Annika Lindblom,Artitaya Lophatananon,Robert Luben,Jan Lubinski,Arto Mannermaa,Mehdi Manoochehri,Siranoush Manoukian,Sara Margolin,Shivaani Mariapun,Keitaro Matsuo,Tabea Maurer,Dimitrios Mavroudis,Alfons Meindl,Usha Menon,Roger L. Milne,Roger L. Milne,Roger L. Milne,Kenneth Muir,Anna Marie Mulligan,Anna Marie Mulligan,Susan L. Neuhausen,Heli Nevanlinna,Kenneth Offit,Olufunmilayo I. Olopade,Janet E. Olson,Håkan Olsson,Nick Orr,Nick Orr,Sue K. Park,Sue K. Park,Paolo Peterlongo,Julian Peto,Dijana Plaseska-Karanfilska,Nadege Presneau,Brigitte Rack,Rohini Rau-Murthy,Gad Rennert,Hedy S. Rennert,Valerie Rhenius,Atocha Romero,Matthias Ruebner,Emmanouil Saloustros,Rita K. Schmutzler,Andreas Schneeweiss,Andreas Schneeweiss,Christopher G. Scott,Mitul Shah,Chen-Yang Shen,Chen-Yang Shen,Xiao-Ou Shu,Jacques Simard,Christof Sohn,Melissa C. Southey,Melissa C. Southey,Melissa C. Southey,John J. Spinelli,Rulla M. Tamimi,Rulla M. Tamimi,William J. Tapper,Soo Hwang Teo,Soo Hwang Teo,Mary Beth Terry,Diana Torres,Diana Torres,Thérèse Truong,Michael Untch,Celine M. Vachon,Christi J. van Asperen,Alicja Wolk,Alicja Wolk,Taiki Yamaji,Wei Zheng,Argyrios Ziogas,Elad Ziv,Gabriela Torres-Mejía,Thilo Dörk,Anthony J. Swerdlow,Ute Hamann,Marjanka K. Schmidt,Alison M. Dunning,Paul D.P. Pharoah,Douglas F. Easton,Maartje J. Hooning,John W.M. Martens,Antoinette Hollestelle +195 more
TL;DR: Although involved in breast cancer progression, HOXB13 is not a material breast cancer susceptibility gene, as evaluated within 81 studies of the international Breast Cancer Association Consortium containing 68,521 invasive breast cancer patients and 54,865 controls.